PN 75010
RN 00177
AN 76084671
AU Hoiby-N.
TI Prevalence of mucoid strains of Pseudomonas aeruginosa in
   bacteriological specimens from patients with cystic fibrosis and
   patients with other diseases.
SO Acta-Pathol-Microbiol-Scand [Suppl]. 1975 Dec. 83(6). P 549-52.
MJ CYSTIC-FIBROSIS: mi.  PSEUDOMONAS-AERUGINOSA: ip.
MN ADOLESCENCE.  ADULT.  AGED.  CHILD.  CHILD-PRESCHOOL.  FEMALE.
   HUMAN.  INFANT.  INFANT-NEWBORN.  MALE.  MIDDLE-AGE.  PHENOTYPE.
   RESPIRATORY-SYSTEM: mi.
AB The relative prevalence of mucoid strains compared with non-mucoid
   strains of Pseudomonas aeruginosa has been investigated in all
   routine bacteriological specimens received in a department of
   clinical microbiology during 1973. Pseudomonas aeruginosa was
   isolated from 1054 of the specimens (5.7 per cent) representing 53
   patients with cystic fibrosis (551 isolates) and 169 patients with
   other diseases (503 isolates). The relative prevalence of mucoid
   strains was significantly higher in specimens from patients with
   cystic fibrosis (80 per cent) than in specimens from patients with
   other diseases (3 per cent). Considering patients without cystic
   fibrosis, the relative prevalence of mucoid strains was low in
   specimens from all anatomical regions, and no special preference of
   these strains for the respiratory tract could be demonstrated in
   these patients, in contrast to the situation in patients with cystic
   fibrosis. Alternation between mucoid strains and non-mucoid strains
   in subsequent specimens was observed in 33 of the patients.
RF 001   BERGAN T              ACTA PATH MICROBIOL SCAND (B)   83   553 975
   002   BURNS MW              BR MED J                         3   382 973
   003   DIAZ F                J INFECT DIS                   121   269 970
   004   DOGGETT RG            J PEDIATR                       68   215 966
   005   DOGGETT RG            APPL MICROBIOL                  18   936 969
   006   DOGGETT RG            INFECT IMMUN                     6   628 972
   007   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   81   298 973
   008   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974
   009   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974
   010   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   83   459 975
   011   JESSEN O              THESIS                                61 965
   012   MARTIN DR             J MED MICROBIOL                  6   111 973
CT   1   BERGAN T              ACTA PATH MICROBIOL SCAND (B)   83   553 975
     2   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     3   HOIBY N               SCAND J RESPIR DIS              58    65 977
     4   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   85   107 977
     5   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   85   142 977
     6   MARKOWITZ SM          INFECT IMMUN                    22   530 978
     7   SCHIOTZ PO            HUM HERED                       28   293 978
     8   MARESZBABCZYSZYN J    ARCH IMMUNOL THER EXP           27   585 979
     9   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   88   125 980
    10   OHMAN DE              INFECT IMMUN                    33   142 981
    11   HOIBY N               SCAND J INFECT DIS            1981    27 981
    12   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982
    13   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982
    14   DORING G              INFECT IMMUN                    42   197 983
    15   ADLER KB              JAMA                           249  1615 983
    16   WOODS DE              J INFECT DIS                   151   581 985
    17   PEDERSEN SS           ACTA PAEDIATR SCAND             75   840 986
    18   ADLER KB              AM J PATHOL                    125   501 986